Paul Rivard - Insider Trading & Ownership

Entity
Individual
Location
C/O Akers Biosciences, Inc., 1185 Avenue Of The Americas, 3 Rd Floor, New York, NY
Summary
The estimated net worth of Paul Rivard is at least $444K dollars as of August 24, 2023. Paul Rivard is the Chief Legal Officer of MyMD Pharmaceuticals, Inc. and owns shares of TNF Pharmaceuticals, Inc. (TNFA) stock worth about $444K.
All Insider Reports
All Insider Reports

Ownership of Paul Rivard

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TNFA TNF Pharmaceuticals, Inc. Chief Legal Officer $444K Aug 24, 2023

Insider Transactions Reported by Paul Rivard:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.